Пациентите, включени в проучването имат MMSE (минимален преглед на
Clinical studies in Alzheimer’ s dementia The efficacy of Prometax transdermal patches in patients with Alzheimer’ s dementia has been demonstrated in a 24-week double-blind core study and its open-label extension phase.